49 results
8-K
EX-99.1
BEAM
Beam Therapeutics Inc
7 May 24
Beam Therapeutics Reports Pipeline Updates and First Quarter 2024 Financial Results
7:09am
authorisation (CTA) application by the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency for BEAM-302, the company’s priority genetic
8-K
EX-99.1
BEAM
Beam Therapeutics Inc
8 Jan 24
Results of Operations and Financial Condition
6:55am
* BEAM-301GSD1a Submit U.S. IND application in first half of 2024 BEAM-201T-ALL / T-LL Present clinical data in second half of 2024 *assuming CTA acceptance
THANK YOU J.P. MORGAN HEALTHCARE CONFERENCE JANUARY 2024
8-K
EX-99.2
fde pqxe7a316
8 Jan 24
Results of Operations and Financial Condition
6:55am
8-K
azp2p7
8 Jan 24
Results of Operations and Financial Condition
6:55am
8-K
EX-99.1
rdy1ssiltflh2kdx
14 Dec 23
Beam Therapeutics Appoints Biotech Executive Christi Shaw to its Board of Directors
4:05pm
8-K
inszaw
10 Jan 22
Results of Operations and Financial Condition
6:45am
8-K
EX-99.2
y26x1f1 kwzwslv
10 Jan 22
Results of Operations and Financial Condition
6:45am
S-3ASR
98aag sou
10 Jun 21
Automatic shelf registration
7:03am